This brand name is authorized in Japan
The drug GRAMALIL contains one active pharmaceutical ingredient (API):
1
Tiapride
UNII 25N106WEDO - TIAPRIDE HYDROCHLORIDE
|
Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine). |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N05AL03 | Tiapride | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1190004C1025, 1190004F1021, 1190004F2028 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.